Jan 06, 2020
Bioness StimRouter® Neuromodulation System Receives CE Mark Approval for the Treatment of Fecal Incontinence
Nov 12, 2018
More Rural Family Medicine Practices Enrolled in Practice Transformation Networks
Nov 01, 2018
The Journal of Urology Publishes Valencia's Excellent Feasibility Data on eCoin(TM) for Overactive Bladder
Aug 30, 2018
BlueWind Medical Announces Positive Long-Term Results of the BLUEWIND-RENOVA(TM) Implantable Tibial Nerve Neuromodulator
Jun 14, 2018
BlueWind Medical Receives FDA Approval for Pivotal Trial Design of RENOVA iStim(TM) Implantable Tibial Nerve Neuromodulator for Overactive Bladder
Apr 23, 2018
LABORIE Medical Technologies and Cogentix Medical Announce Completion of Acquisition of Cogentix Medical by LABORIE Medical Technologies
Apr 06, 2018
Global Drugs for Urinary Incontinence and Overactive Bladder Markets to 2022: Focus on Idiopathic Bladder Overactivity, and Neurogenic Bladder Overactivity
Mar 12, 2018
LABORIE Medical Technologies to acquire Cogentix Medical Inc., for $214 million
Mar 01, 2018
Cogentix Medical to Report Fourth Quarter and Full Year 2017 Financial Results on March 12, 2018
Dec 06, 2017
Cogentix Medical Announces Palmetto GBA Extends Medicare Coverage on Urgent® PC
Nov 09, 2017
Valencia Technologies to Present at Canaccord Genuity Medical Technologies & Diagnostics Forum
Oct 25, 2017
Cogentix Medical to Report Third Quarter Results on November 7, 2017
Sep 28, 2017
Cogentix Medical Makes $2 Million Investment in Israeli Company Developing Innovative and Novel Device for Delivery of Drugs to the Bladder
Sep 13, 2017
Cogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance Therapy
Jul 26, 2017
Cogentix Medical Acquires Genesis Medical; Transaction to Further Increase Urology Products Revenue Growth Rate